H2020HORIZONFP7
Oslo Universitetssykehus Hf
- Country
- NONorway
- Defence projects
- 0
- Projects, all programmes
- 111
- As coordinator
- 19
- EU contribution (CORDIS)
- EUR 51,564,813
- Active
- 2008 to 2026
Projects
111 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| INNODIATranslational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797 | H2020 | 2015 | Participant | EUR 409,901 |
| MELGENMELanoma GENetics - understanding and biomarking the genetic and immunological determinants of melanoma survival | H2020 | 2015 | Participant | EUR 572,550 |
| TOXI-triageINTEGRATED AND ADAPTIVE RESPONSES TO TOXIC EMERGENCIES FOR RAPID TRIAGE: ENGINEERING THE ROADMAP FROM CASUALTY TO PATIENT TO SURVIVOR. | H2020 | 2015 | Participant | EUR 740,549 |
| INTUI-VIEWIntelligent needle tracking using ultrasound imaging for improved minimally invasive interventions | H2020 | 2015 | Participant | EUR 686,453 |
| CANCER-IDCancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood | FP7 | 2015 | Participant | EUR 80,000 |
| PRECIOUSPREvention of Complications to Improve OUtcome in elderly patients with acute Stroke | H2020 | 2015 | Participant | EUR 329,751 |
| ESMARTRandomised controlled trial to evaluate electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology for patients with cancers | FP7 | 2014 | Participant | Not stated |
| TACTICTargeted Action for Curing Trauma Induced Coagulopathy | FP7 | 2013 | Participant | EUR 172,182 |
| CENTER-TBICollaborative European NeuroTrauma Effectiveness Research in TBI | FP7 | 2013 | Participant | EUR 109,908 |
| HYPERTAMEvaluation of the synergy between tamoxifen chemotherapy and hypericin photodynamic action, following mitochondrial complex III photo-inhibition: Towards a combinatorial anticancer treatment modality | FP7 | 2013 | Coordinator | EUR 301,251 |
| PROFNAITDevelopment of a prophylactic treatment for the prevention of fetal/neonatal alloimmune thrombocytopenia (FNAIT) | FP7 | 2012 | Participant | EUR 57,965 |
| GLYCOHITGlycomics by High-throughput Integrated Technologies | FP7 | 2011 | Participant | EUR 90,600 |
| VIBE-FGS-EUSANPrevention and improved diagnosis of adolescent genital disease in schistosomiasis endemic KwaZulu-Natal, South Africa | FP7 | 2011 | Coordinator | EUR 254,100 |
| DynICPInnovative Intracranial Pressure and Volume Wave Monitoring System | FP7 | 2011 | Participant | EUR 75,168 |
| I-SURIntelligent Surgical Robotics | FP7 | 2011 | Participant | EUR 500,000 |
| BAMIThe effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all-cause mortality in acute myocardial infarction | FP7 | 2011 | Participant | Not stated |
| EUROCANPLATFORMA European Platform for Translational Cancer Research | FP7 | 2011 | Participant | EUR 647,900 |
| MITOCARETreatment of reperfusion injury using a mitochondrial targeted approach: towards a better understanding of the disease | FP7 | 2011 | Participant | EUR 201,530 |
| EPI-CTEpidemiological study to quantify risks for paediatric computerized tomography and to optimise doses. | FP7 | 2011 | Participant | Not stated |
| INTREALLInternational study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and research | FP7 | 2011 | Participant | EUR 102,300 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.